Results 131 to 140 of about 123,340 (264)
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon +11 more
wiley +1 more source
Alumina-Based Cutting Tools-A Review of Recent Progress. [PDF]
Žmak I +3 more
europepmc +1 more source
Investigation of the Wear Performance of TiB2 Coated Cutting Tools during the Machining of Ti6Al4V Alloy. [PDF]
Chowdhury MSI +3 more
europepmc +1 more source
Advancing Age Modulates Associations Between Cognitive Impairment and Brain Volumes in Early MS
ABSTRACT Introduction Cognitive impairment is common in multiple sclerosis (MS), but manifestations following the first demyelinating event are relatively unexplored. We investigated cross‐sectional associations between magnetic resonance imaging (MRI)–derived brain volumes and the presence of cognitive impairment outcomes five years after the first ...
Piriyankan Ananthavarathan +14 more
wiley +1 more source
Advanced fault diagnosis in milling cutting tools using vision transformers with semi-supervised learning and uncertainty quantification. [PDF]
Siddique MF, Umar M, Ahmad W, Kim JM.
europepmc +1 more source
ABSTRACT Background X‐linked adrenoleukodystrophy (X‐ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1, leading to slowly progressive spinal cord disease in nearly all affected men. Sensitive biomarkers to quantify disease severity and predict progression are needed for clinical care and trial design.
Eda G. Kabak +4 more
wiley +1 more source
Tribological Effects of Surface Biomimetic Micro-Nano Textures on Metal Cutting Tools: A Review. [PDF]
Sheng Z +5 more
europepmc +1 more source
Diamond-reinforced cutting tools using laser-based additive manufacturing. [PDF]
Traxel KD, Bandyopadhyay A.
europepmc +1 more source
Predictive Ability of Plasma p‐tau217 for β‐Amyloid Status: A Prospective Multicenter Study
ABSTRACT Objective Plasma tau phosphorylated at threonine 217 (p‐tau217) measured with fully automated platforms has shown high accuracy for Alzheimer's disease (AD) diagnosis, but real‐world multicenter data remain limited. We aimed to validate the diagnostic performance of p‐tau217 for identifying AD pathology in a real‐world multicenter cohort ...
Miquel Massons +33 more
wiley +1 more source

